Reprogramming human endometrial fibroblast into induced pluripotent stem cells

Taiwanese Journal of Obstetrics and Gynecology

Volumn 51, Issue 1, 2012, Pages 35-42

  Chen, Yi Jen ^a,d   Liou, Ying Jay ^a,d   Chang, Chia Ming ^a,d   Li, Hsin Yang ^a,d   Chen, Chih Yao ^a,d   Twu, Nae Fang ^a,d   Yen, Ming Shyen ^a,d   Chang, Yuh Lih ^a,d   Peng, Chi Hsien ^b,d   Chiou, Shih Hwa ^d   Chen, Chih Ping ^c,d   Chao, Kuan Chong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Differentiation; Endometrial fibroblasts; Endometrium; Gene; Inducible pluripotent stem cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; ENDOMETRIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL;

ADIPOCYTES; ADULT; CELL DIFFERENTIATION; ENDOMETRIUM; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEURAL STEM CELLS; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOCYTES; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 84862794946     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2012.01.008     Document Type: Article

References (31)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
3. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
4. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
5. Maherali N., Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 3:595-605.
6. Cox J.L., Rizzino A. Induced pluripotent stem cells: what lies beyond the paradigm shift. Exp Biol Med (Maywood) 2010, 235:148-158.
7. Colman A., Dreesen O. Induced pluripotent stem cells and the stability of the differentiated state. EMBO Rep 2009, 10:714-721.
8. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flügel L., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010, 363:1397-1409.
9. Tsuji O., Miura K., Okada Y., Fujiyoshi K., Mukaino M., Nagoshi N., et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 2010, 107:12704-12709.
10. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
11. Chen S.J., Chang C.M., Tsai S.K., Chang Y.L., Chou S.J., Huang S.S., et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 2010, 19:1757-1767.
12. Chan R.W., Schwab K.E., Gargett C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004, 70:1738-1750.
13. Gargett C.E., Chan R.W., Schwab K.E. Endometrial stem cells. Curr Opin Obstet Gynecol 2007, 19:377-383.
14. Chen Y.J., Li H.Y., Chang Y.L., Yuan C.C., Tai L.K., Lu K.H., et al. Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertil Steril 2010, 94:1972-1979.
15. Meng X., Ichim T.E., Zhong J., Rogers A., Yin Z., Jackson J., et al. Endometrial regenerative cells: a novel stem cell population. J Transl Med 2007, 5:57.
16. Park J.H., Daheron L., Kantarci S., Lee B.S., Teixeira J.M. Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells. Endocrinology 2011, 152:1080-1089.
17. Li H.Y., Chen Y.J., Chen S.J., Kao C.L., Tseng L.M., Lo W.L., et al. Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells. J Pharmacol Exp Ther 2010, 335:817-829.
18. Gauthaman K., Fong C.Y., Bongso A. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Rev 2010, 6:86-95.
19. Hida N., Nishiyama N., Miyoshi S., Kira S., Segawa K., Uyama T., et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26:1695-1704.
20. Kao C.L., Tai L.K., Chiou S.H., Chen Y.J., Lee K.H., Chou S.J., et al. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 2010, 19:247-258.
21. Kao H.T., Li P., Chao H.M., Janoschka S., Pham K., Feng J., et al. Early involvement of synapsin III in neural progenitor cell development in the adult hippocampus. J Comp Neurol 2008, 507:1860-1870.
22. Yang D.C., Tsay H.J., Lin S.Y., Chiou S.H., Li M.J., Chang T.J., et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One 2008, 3:e1540.
23. Gray C.A., Bartol F.F., Tarleton B.J., Wiley A.A., Johnson G.A., Bazer F.W., et al. Developmental biology of uterine glands. Biol Reprod 2001, 65:1311-1323.
24. Schuring A.N., Schulte N., Kelsch R., Ropke A., Kiesel L., Götte M. Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertil Steril 2011, 95:423-426.
25. Tsuji S., Yoshimoto M., Takahashi K., Noda Y., Nakahata T., Heike T. Side population cells contribute to the genesis of human endometrium. Fertil Steril 2008, 90:1528-1537.
26. Nakagawa M., Takizawa N., Narita M., Ichisaka T., Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A 2010, 107:14152-14157.
27. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
28. Chambers S.M., Studer L. Cell fate plug and play: direct reprogramming and induced pluripotency. Cell 2011, 145:827-830.
29. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
30. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
31. Szabo E., Rampalli S., Risueno R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.